Pieris Pharmaceuticals
PIRS
$9.81
Share price
5.83%
Change (1 day)
5,671.00%
Change (1 year)
Categories
EPS for Pieris Pharmaceuticals (PIRS)
EPS in 2023 (TTM): -$0.37
According to Pieris Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.37. In 2022 the company made an earnings per share (EPS) of -$0.45 an increase over its 2021 EPS that were of -$0.69.
EPS history for Pieris Pharmaceuticals from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.37 | -17.78% |
| 2022 | -$0.45 | -34.78% |
| 2021 | -$0.69 | 1.47% |
| 2020 | -$0.68 | 23.64% |
| 2019 | -$0.55 | 11.39% |
| 2018 | -$0.49 | 23.44% |
| 2017 | -$0.40 | -25.93% |
| 2016 | -$0.54 | 28.57% |
| 2015 | -$0.42 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $4.39 | -1,286.49% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | -$4.66 | 1,159.46% | 🇺🇸 USA |